Cargando…

Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F35

Adoptive transfer of genetically-modified T cells is a promising approach for treatment of both human malignancies and viral infections. Due to its ability to efficiently infect lymphocytes, the chimeric adenovirus Ad5F35 is potentially useful as an immunotherapeutic for the genetic modification of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wen-feng, Shao, Hong-wei, Wu, Feng-lin, Xie, Xin, Li, Zhu-Ming, Bo, Hua-Ben, Shen, Han, Wang, Teng, Huang, Shu-lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789598/ https://www.ncbi.nlm.nih.gov/pubmed/26972139 http://dx.doi.org/10.1038/srep22688

Ejemplares similares

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020)

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma
por: Yang, Ming, et al.
Publicado: (2018)

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
por: Flickinger, John C., et al.
Publicado: (2022)

The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
por: Shin, Seung-Phil, et al.
Publicado: (2022)

Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
por: Koodie, Lisa, et al.
Publicado: (2019)

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells
por: Gao, Jian, et al.
Publicado: (2020)

Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
por: Cho, Young-Suk, et al.
Publicado: (2016)

Killing Effect of Ad5/F35-APE1 siRNA Recombinant Adenovirus in Combination with Hematoporphrphyrin Derivative-Mediated Photodynamic Therapy on Human Nonsmall Cell Lung Cancer
por: Xia, Lei, et al.
Publicado: (2013)

Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
por: Ang, Lin, et al.
Publicado: (2022)

Immunogenic Comparison of Chimeric Adenovirus 5/35 Vector Carrying Optimized Human Immunodeficiency Virus Clade C Genes and Various Promoters
por: Shoji, Masaki, et al.
Publicado: (2012)

Efficient Amplification of Chimeric Adenovirus 5/40S Vectors Carrying the Short Fiber Protein of Ad40 in Suspension Cell Cultures
por: Miralles, Marta, et al.
Publicado: (2012)

Serotype Chimeric Human Adenoviruses for Cancer Gene Therapy
por: Ranki, Tuuli, et al.
Publicado: (2010)

Adenovirus F protein as a delivery vehicle for botulinum B
por: Clapp, Beata, et al.
Publicado: (2010)

Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
por: Santos, Joao, et al.
Publicado: (2021)

Characterization of human adenovirus 35 and derivation of complex vectors
por: McVey, Duncan, et al.
Publicado: (2010)

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022)

The Structural Basis for the Integrity of Adenovirus Ad3 Dodecahedron
por: Szolajska, Ewa, et al.
Publicado: (2012)

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
por: Ono, Ryosuke, et al.
Publicado: (2021)

Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5
por: Lv, Yun, et al.
Publicado: (2019)

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
por: Kudling, Tatiana V., et al.
Publicado: (2022)

Adenoviruses in Lymphocytes of the Human Gastro-Intestinal Tract
por: Roy, Soumitra, et al.
Publicado: (2011)

Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy
por: Sakamoto, Shuichi, et al.
Publicado: (2019)

Adenovirus receptors and their implications in gene delivery
por: Sharma, Anurag, et al.
Publicado: (2009)

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
por: Penaloza, P, et al.
Publicado: (2012)

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018)

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021)

Chimeric maternal cells as T lymphocyte targets in pediatric SLE
por: Stevens, Anne M, et al.
Publicado: (2012)

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
por: Stroncek, David F., et al.
Publicado: (2017)

Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma
por: Pang, Tao, et al.
Publicado: (2017)

Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35
por: Tuve, Sebastian, et al.
Publicado: (2008)

Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia
por: Kwok, Michelle, et al.
Publicado: (2021)

Adenovirus Dodecahedron, as a Drug Delivery Vector
por: Zochowska, Monika, et al.
Publicado: (2009)

Retargeted adenoviruses for radiation-guided gene delivery
por: Kaliberov, S A, et al.
Publicado: (2016)

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2017)

Interleukin-24 enhancing antitumor activity of chimeric oncolytic adenovirus for treating acute promyelocytic leukemia cell
por: Liu, Li, et al.
Publicado: (2019)

F. F. F. F.—2000 A.D
por: Rogers, James Frederick
Publicado: (1947)

Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection
por: Wang, Shen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4429b237e970l438mr2pd3juiv